Skip to main content

Animations

MJFF Publications

7821 - 7830 of 9145 Results
Title
Year
  • Year
  • 2021
  • 2023
  • 2019
  • 2019
  • 2019
  • 2018
  • 2019
  • 2019
  • 2019
  • 2020
  • Summary Details
    OPEN
    Title: Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.12254
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Preface to the 4th MDS Video Challenge Case Supplement for Movement Disorders Clinical Practice
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13832
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Nonlinear Z‐score modeling for improved detection of cognitive abnormality
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dadm.2019.08.003
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Multimodal dopaminergic and free-water imaging in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.007
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.040
    Citation Count: 43
  • Ultra–Low-Dose18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs
    2018
    Summary Details
    RESTRICTED
    Title: Ultra–Low-Dose18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs
    Journal Name: Radiology
    Publisher: Radiological Society of North America (RSNA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1148/radiol.2018180940
    Citation Count: 250
  • Summary Details
    OPEN
    Title: OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.009
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Deubiquitinase USP29 Governs MYBBP1A in the Brains of Parkinson’s Disease Patients
    Journal Name: Journal of Clinical Medicine
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/jcm9010052
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-191576
    Citation Count: 130
  • Summary Details
    OPEN
    Title: Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.12240
    Citation Count: 23
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.